S. H. Lowe

Antiretroviral therapy in previously untreated adults infected with the human immunodeficiency virus type I: established and potential determinants of virological outcome.

J. Prins, J. Lange, S. Lowe, 2004, The Netherlands journal of medicine.

Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy

T. Hankemeier, A. Harms, A. Boonstra, 2018, Scientific Reports.

No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis

P. Stassen, R. Dennert, J. de Kort, 2016, Infectious diseases.

Is the male genital tract really a sanctuary site for HIV? Arguments that it is not.

P. Reiss, S. Repping, J. Lange, 2004, AIDS.

Antiretroviral therapy : efficacy and toxicity in the ARES study and responses in the male genital tract

S. H. Lowe, 2007 .

Brief Report: Stavudine but not Didanosine as Part of HAART Contributes to Peripheral Lipoatrophy: A Substudy from the Antiretroviral Regimen Evaluation Study (ARES)

P. Reiss, B. van Eck-Smit, J. Lange, 2007, HIV clinical trials.

Inosine Triphosphate Pyrophosphohydrolase Expression: Decreased in Leukocytes of HIV-Infected Patients Using Combination Antiretroviral Therapy

B. J. van den Bosch, A. Paulussen, J. Bierau, 2016, Journal of acquired immune deficiency syndromes.

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study

W. Bierman, M. van der Valk, Q. de Mast, 2022, PLoS medicine.

Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activity

E. Andrinopoulou, B. J. van den Bosch, A. Paulussen, 2018, The Journal of antimicrobial chemotherapy.

Virological and Social Outcomes of HIV-Infected Adolescents and Young Adults in The Netherlands Before and After Transition to Adult Care.

G. Driessen, P. Reiss, W. Bierman, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Similar virologic response after initiation of triple-class antiretroviral therapy in primary and chronic HIV infection.

F. Wit, F. de Wolf, J. Prins, 2012, AIDS.